BMC Nephrology | |
Picking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluation | |
Zhihong Liu1  Caihong Zeng1  Song Jiang1  Xianghua Huang1  Qiquan Sun1  | |
[1] Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, 210002, China | |
关键词: Transplant glomerulopathy; Hepatitis C virus; Chronic allograft nephropathy; Antibody-mediated injury; | |
Others : 1083083 DOI : 10.1186/1471-2369-13-128 |
|
received in 2011-11-24, accepted in 2012-09-24, 发布年份 2012 | |
【 摘 要 】
Background
Since the term chronic allograft nephropathy (CAN) was removed from the Banff scheme in 2005, transplant glomerulopathy (TG) has been regarded as a clinicopathological entity that is one of the major causes of graft loss. To assess the distinction between CAN and TG, we performed a comprehensive evaluation comparing TG with traditional CAN.
Methods
We compared the clinicopathological features of 43 cases of TG with 43 matched cases of non-TG CAN (non-TG group) after renal transplantation. TG was diagnosed by light microscopy based on the double contours of the glomerular basement membranes, and the Banff 97 classification system was used to score TG severity (cg0-3).
Results
Compared to the control group, we found a significantly higher incidence of positivity for human leukocyte antigen class-I and II antibodies, a higher incidence of hepatitis C virus (HCV) infection, and poorer graft survival in TG patients. Clinically, TG was associated with a higher prevalence of proteinuria, hematuria, anaemia and hypoalbuminemia. Histologically, TG strongly correlated with antibody related microcirculatory injuries, including glomerulitis, peritubular capillaritis and peritubular capillary (PTC) C4d deposition. Interestingly, the TG patients showed a significantly higher incidence of IgA deposition than the control patients. C4d-positive TG was correlated with higher TG and PTC scores, and PTC C4d deposition was correlated with a more rapid progression to graft dysfunction. TG accompanied by HCV infection was associated with heavier proteinuria, higher TG and C4d scores, and poorer graft survival.
Conclusions
TG presents clinicopathological features that are distinct from non-TG cases and leads to poorer outcomes. PTC C4d deposition is related to a more rapid progression to graft loss, suggesting ongoing antibody reactivity. HCV-positive TG is a more severe sub-entity, that requires further investigation.
【 授权许可】
2012 Sun et al.; licensee BioMed Central Ltd.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
20141224194414471.pdf | 481KB | download | |
Figure 5. | 22KB | Image | download |
Figure 4. | 25KB | Image | download |
Figure 3. | 28KB | Image | download |
Figure 2. | 26KB | Image | download |
Figure 1. | 30KB | Image | download |
【 图 表 】
Figure 1.
Figure 2.
Figure 3.
Figure 4.
Figure 5.
【 参考文献 】
- [1]Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, et al.: Banff ‘05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (‘CAN’). Am J Transplant 2007, 7:518-526.
- [2]Fotheringham J, Angel CA, McKane W: Transplant glomerulopathy: morphology, associations and mechanism. Nephron Clin Pract 2009, 113:1-7. discussion c7
- [3]Haas M: Transplant glomerulopathy: it's not always about chronic rejection. Kidney Int 2011, 80:801-803.
- [4]Cosio FG, Gloor JM, Sethi S, Stegall MD: Transplant glomerulopathy. Am J Transplant 2008, 8:492-496.
- [5]Mauiyyedi S, Pelle PD, Saidman S, Collins AB, Pascual M, Tolkoff-Rubin NE, Williams WW, Cosimi AA, Schneeberger EE, Colvin RB: Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001, 12:574-582.
- [6]Gloor J, Cosio F, Lager DJ, Stegall MD: The spectrum of antibody-mediated renal allograft injury: implications for treatment. Am J Transplant 2008, 8:1367-1373.
- [7]Akalin E, Dinavahi R, Dikman S, de Boccardo G, Friedlander R, Schroppel B, Sehgal V, Bromberg JS, Heeger P, Murphy B: Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining. Clin J Am Soc Nephrol 2007, 2:1261-1267.
- [8]Sis B, Campbell PM, Mueller T, Hunter C, Cockfield SM, Cruz J, Meng C, Wishart D, Solez K, Halloran PF: Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007, 7:1743-1752.
- [9]Einecke G, Sis B, Reeve J, Mengel M, Campbell PM, Hidalgo LG, Kaplan B, Halloran PF: Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009, 9:2520-2531.
- [10]Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, et al.: The Banff 97 working classification of renal allograft pathology. Kidney Int 1999, 55:713-723.
- [11]Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, et al.: Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008, 8:753-760.
- [12]Shimizu T, Ishida H, Shirakawa H, Omoto K, Tsunoyama K, Iida S, Tanabe K, Yamaguchi Y: Clinicopathological analysis of transplant glomerulopathy cases. Clin Transplant 2009, 23(Suppl 20):39-43.
- [13]Gloor JM, Sethi S, Stegall MD, Park WD, Moore SB, DeGoey S, Griffin MD, Larson TS, Cosio FG: Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant 2007, 7:2124-2132.
- [14]Bohmig GA, Bartel G, Wahrmann M: Antibodies, isotypes and complement in allograft rejection. Curr Opin Organ Transplant 2008, 13:411-418.
- [15]Al AZ, Yalamanchili P, Cortese C, Salinas-Madrigal L, Bastani B: C4d peritubular capillary staining in chronic allograft nephropathy and transplant glomerulopathy: an uncommon finding. Transpl Int 2005, 18:800-805.
- [16]Batal I, Girnita A, Zeevi A, Saab BA, Stockhausen S, Shapiro R, Basu A, Tan H, Morgan C, Randhawa P: Clinical significance of the distribution of C4d deposits in different anatomic compartments of the allograft kidney. Mod Pathol 2008, 21:1490-1498.
- [17]Sijpkens YW, Joosten SA, Wong MC, Dekker FW, Benediktsson H, Bajema IM, Bruijn JA, Paul LC: Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney Int 2004, 65:2409-2418.
- [18]Vongwiwatana A, Gourishankar S, Campbell PM, Solez K, Halloran PF: Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. Am J Transplant 2004, 4:124-129.
- [19]Plissonnier D, Henaff M, Poncet P, Paris E, Tron F, Thuillez C, Michel JB: Involvement of antibody-dependent apoptosis in graft rejection. Transplantation 2000, 69:2601-2608.
- [20]Cosio FG, Grande JP, Larson TS, Gloor JM, Velosa JA, Textor SC, Griffin MD, Stegall MD: Kidney allograft fibrosis and atrophy early after living donor transplantation. Am J Transplant 2005, 5:1130-1136.
- [21]Kieran N, Wang X, Perkins J, Davis C, Kendrick E, Bakthavatsalam R, Dunbar N, Warner P, Nelson K, Smith KD, et al.: Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure. J Am Soc Nephrol 2009, 20:2260-2268.
- [22]John R, Konvalinka A, Tobar A, Kim SJ, Reich HN, Herzenberg AM: Determinants of long-term graft outcome in transplant glomerulopathy. Transplantation 2010, 90:757-764.
- [23]Suri DL, Tomlanovich SJ, Olson JL, Meyer TW: Transplant glomerulopathy as a cause of late graft loss. Am J Kidney Dis 2000, 35:674-680.
- [24]Cosio FG, Sedmak DD, Henry ML, Al HC, Falkenhain ME, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM: The high prevalence of severe early posttransplant renal allograft pathology in hepatitis C positive recipients. Transplantation 1996, 62:1054-1059.
- [25]Baid-Agrawal S, III FAB, Pascual M, Mauiyyedi S, Farrell ML, Tolkoff-Rubin N, Collins AB, Frei U, Colvin RB: Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney Int 2011, 80:879-885.
- [26]Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, Xie J, Sanna-Cherchi S, Men CJ, Julian BA, Wyatt RJ, et al.: Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 2011, 43:321-327.
- [27]Feehally J, Farrall M, Boland A, Gale DP, Gut I, Heath S, Kumar A, Peden JF, Maxwell PH, Morris DL, et al.: HLA has strongest association with IgA nephropathy in genome-wide analysis. J Am Soc Nephrol 2010, 21:1791-1797.